Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the dose responsiveness of ringer lactate solution in prevention of post-induction hypotension predicted by Ultrasound guided Inferior Vena Cava diameter in patients receiving General anesthesia.
OBJECTIVES Primary - To find the optimum preloading dosage of Ringer Lactate to prevent post induction hypotension.
Secondary - To find the predictive incidence of Post-induction hypotension according to age, gender, type of surgery and comorbidities.
All patients, after Ultrasonographic Inferior vena cava collapsibility index calculation, will receive Lactated Ringer's solution as per body weight and as per their allocated group in the receiving area.
After induction inside the Operating Room, All patients will be monitored continuously using Electrocardiography, pulse oximetry, noninvasive Blood pressure measurement and capnography .
Heart rate, Systolic - Diastolic - Mean blood pressure, Oxygen saturation will be monitored as follows :
Amount of Mephentermine needed to correct hypotension despite RL infusion will also be calculated.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RL 10 | Active Comparator | Patients of this group will receive Ringer's lactate (RL) 10ml/kg |
|
| RL 15 | Active Comparator | Patients of this group will receive 15ml/kg of Ringer's lactate solution |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RL 10ml/kg | Other | Inferior vena cava collapsibility index of all patients will be calculated by ultrasonography and if it is >50%, then patients of this group (Group 1) will receive Ringer's lactate 10ml/kg before induction in the receiving area |
| Measure | Description | Time Frame |
|---|---|---|
| Effective dose of Ringer's lactate solution to prevent post-induction hypotension | This study will try to find out the effective dose of Ringer's lactate solution in ml/Kg that will prevent hypotension after induction of anaesthesia in study population | 15 months |
| Measure | Description | Time Frame |
|---|---|---|
| Effect of age, gender, types of surgery and comorbid conditions on post-induction hypotension | This study will try to find out the effect of age, gender, type of surgery and type of comorbid conditions (like Diabetes, Hypertension etc) on occurence of post-induction hypotension by measuring the % of hypotension in these categories of patients | 15 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chatterjee | Contact | +917763807075 | dr.abhishek@tatasteel.com | |
| Merina Sam | Contact | +919168334563 | merinasam96@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Abhishek Chatterjee | Tata Steel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Abhishek Chatterjee | Recruiting | Jamshedpur | Jharkhand | 831001 | India |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| RL 15ml/kg | Other | Inferior vena cava collapsibility index of all patients will be calculated by ultrasonography and if it is >50%, then patients of this group (Group 2) will receive Ringer's lactate 15ml/kg before induction in the receiving area |
|